BioSpace News Archive

Business

MOLOGEN Signs License Deal for China and Global Co-Development Agreement with ONCOLOGIE for Lead Compound lefitolimod

MOLOGEN announced today the signing of a license deal for the Chinese territory and a global co-development agreement between MOLOGEN and ONCOLOGIE Inc. for its lead compound lefitolimod.

February 13, 2018

·

6 min read

Business

Digirad Corporation to Release 2017 Fourth Quarter and Year-End Financial Results on February 23, 2018

A conference call is scheduled for 11:00 a.m. EST (8:00 a.m. PST) on February 23, 2018 to discuss the results and management’s outlook. The call may be accessed by dialing 1-877-407-9039 (international callers +1-201-689-8470).

February 13, 2018

·

3 min read

GN Store Nord: Transactions in Relation to Share Buyback Program – Feb. 13, 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

February 13, 2018

·

2 min read

Biotage Release: New ISOLUTE HYDRO DME+ Rapidly Removes Matrix Interferences From Urine

Biotage is pleased to announce the launch of ISOLUTE HYDRO DME+ fixed well plates and columns, for the efficient removal of matrix components from urine, using a simple pass through workflow.

February 13, 2018

·

1 min read

Biotech Bay

Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

KindredBio will participate in the Bank of America Merrill Lynch Animal Health Summit on February 26, 2018 in New York City.

February 13, 2018

·

1 min read

Drug Development

ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase

Following these very encouraging results, ERYTECH conducted a comprehensive evaluation to determine other potential solid-tumor indications for developing eryaspase.

February 13, 2018

·

8 min read

Business

Daré Bioscience Announces Proposed Public Offering of Common Stock

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

February 13, 2018

·

3 min read

BioMidwest

SCORR Marketing and Applied Clinical Trials Release Survey Report on Patient Engagement

SCORR Marketing, a global health science marketing and communications firm, has announced that a new Patient Engagement Survey Report is available for free download.

February 13, 2018

·

2 min read

BioMidwest

Largest Shareholder of ZIVO Bioscience to Extend Maturity Date of Its Convertible Debt

In a related filing, HEP has agreed to extend the maturity date on $16.7 million of its Secured Convertible Promissory Note, including all related interest payments, from September 30, 2018 to April 1, 2019.

February 13, 2018

·

2 min read

Pharm Country

Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells

Cellectis announced today the issuance of two U.S. patents - US 9,855,297 and US 9,890,393 - for the invention of certain uses of RNA-guided endonucleases, such as Cas9 or Cpf1, for the genetic engineering of T-cells.

February 13, 2018

·

5 min read